Ann: Appendix 4D & Financial Statements, page-23

Disappointing revenue figures. Milestone dates keep moving to the right and the wording around the Philips healthcare collaboration doesnt have me as excited as the initial comment back in early 2020.

I'd say this is a hold at the moment and not a buy. Hype around Phillip healthcare and PainChek infant may impact the SP but the figures dont lie. Without the government grant we'd be at 2c again. They need to get their finger out. The covid excuse is wearing thin now. I thought they were covid proof on their chat with Phil Carey April 2020 with digital sales and delivery method? Appears not now.

Hopefully they double up the PainChek universal news release in March with some contract news.